UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036563
Receipt number R000041657
Scientific Title Training with Hybrid Assistive Limb for patients with neurodegenerative disease
Date of disclosure of the study information 2019/04/21
Last modified on 2022/10/23 12:42:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Training with Hybrid Assistive Limb for patients with neurodegenerative disease

Acronym

Training with Hybrid Assistive Limb for patients with neurodegenerative disease

Scientific Title

Training with Hybrid Assistive Limb for patients with neurodegenerative disease

Scientific Title:Acronym

Training with Hybrid Assistive Limb for patients with neurodegenerative disease

Region

Japan


Condition

Condition

neurodegenerative disease

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of Hybrid assistive limb (HAL) for the patients with neurodegenerative disease.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

2 minutes walk, 10 m walk

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

training with HAL

Interventions/Control_2

training without HAL

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with neurodegenerative disease who fulfill the criteria.

Key exclusion criteria

Less than 20-y-o, demented patients

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Osamu
Middle name
Last name Kano

Organization

Toho University Omori Medical Center

Division name

Neurology

Zip code

1438541

Address

6-11-1 Omorinishi Ota-ku Tokyo

TEL

03-3762-4151

Email

osamu.kano@med.toho-u.ac.jp


Public contact

Name of contact person

1st name Osamu
Middle name
Last name Kano

Organization

Toho University Omori Medical Center

Division name

Neurology

Zip code

1438541

Address

6-11-1 Omorinishi Ota-ku Tokyo

TEL

03-3762-4151

Homepage URL


Email

osamu.kano@med.toho-u.ac.jp


Sponsor or person

Institute

Toho University Omori Medical Center

Institute

Department

Personal name



Funding Source

Organization

Department of Neurology, Toho University Omori Medical Center

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Toho University Omori Medical Center

Address

6-11-1 Omorinishi Ota-ku Tokyo

Tel

03-3762-4151

Email

osamu.kano@med.toho-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 04 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 12 Month 26 Day

Date of IRB

2018 Year 12 Month 26 Day

Anticipated trial start date

2018 Year 12 Month 26 Day

Last follow-up date

2023 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 04 Month 21 Day

Last modified on

2022 Year 10 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041657


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name